Literature DB >> 17705040

Glycolitic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsy.

A Martínez1, E Dalfó, G Muntané, I Ferrer.   

Abstract

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder pathologically characterized by neuronal loss and gliosis mainly in specific subcortical nuclei, but also in the cerebral cortex. In addition to neuron loss, hyperphosphorylated tau deposition is found in neurons, astrocytes and coiled bodies. Limited studies have shown that certain oxidative products are increased in the PSP brain. The present study examines oxidative damage in the frontal cortex in 7 PSP compared with 8 age-matched controls. Western blotting of the frontal cortex showed increased 4-hydroxy-2-nonenal (HNE)-immunoreactive bands between 40 and 50 kDa in PSP cases. Bi-dimensional gel electrophoresis and Western blotting, together with mass spectometry, were used to identify HNE-modified proteins. Oxidized phosphoglycerate kinase 1 (PGK-1) and fructose bisphosphate aldolase A (aldolase A) were identified in all cases and 4 of 7 PSP cases, respectively. In contrast, PGK-1 and aldolase A were oxidized in 3 of 8 controls. Immunohistochemistry revealed the localization of aldolase A in neurons and astrocytes, and PGK-1 mainly in astrocytes. These findings show that PGK-1 and aldolase A are targets of oxidation in the frontal cortex in the aged human cerebral cortex and that oxidative damage of these proteins is markedly increased in the frontal cortex in PSP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705040     DOI: 10.1007/s00702-007-0800-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  23 in total

1.  Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.

Authors:  H Karbe; M Grond; M Huber; K Herholz; J Kessler; W D Heiss
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

Review 2.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

3.  Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment.

Authors:  D S Albers; S J Augood; L C Park; S E Browne; D M Martin; J Adamson; M Hutton; D G Standaert; J P Vonsattel; G E Gibson; M F Beal
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

4.  Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles.

Authors:  K Ikeda; H Akiyama; T Arai; T Nishimura
Journal:  Neurobiol Aging       Date:  1998 Jan-Feb       Impact factor: 4.673

5.  Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.

Authors:  Tomaso Scaravilli; Eduardo Tolosa; Isidre Ferrer
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

6.  Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy.

Authors:  D S Albers; S J Augood; D M Martin; D G Standaert; J P Vonsattel; M F Beal
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

Review 7.  Progressive supranuclear palsy: a systematic review.

Authors:  L Rampello; V Buttà; R Raffaele; I Vecchio; G Battaglia; G Cormaci; A Alvano
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

8.  Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.

Authors:  M Bigl; J Apelt; K Eschrich; R Schliebs
Journal:  J Neural Transm (Vienna)       Date:  2003-01       Impact factor: 3.575

9.  Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

Authors:  I Litvan; J J Hauw; J J Bartko; P L Lantos; S E Daniel; D S Horoupian; A McKee; D Dickson; C Bancher; M Tabaton; K Jellinger; D W Anderson
Journal:  J Neuropathol Exp Neurol       Date:  1996-01       Impact factor: 3.685

Review 10.  Update on progressive supranuclear palsy.

Authors:  Irene Litvan
Journal:  Curr Neurol Neurosci Rep       Date:  2004-07       Impact factor: 5.081

View more
  10 in total

1.  Relationship between uric acid levels and progressive supranuclear palsy.

Authors:  David M Brody; Irene Litvan; Steve Warner; David E Riley; Deborah A Hall; Benzi M Kluger; David R Shprecher; Christopher R Cunningham
Journal:  Mov Disord       Date:  2016-02-18       Impact factor: 10.338

2.  Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery.

Authors:  Xiangmin Lin; Min Shi; Jeyaraj Gunasingh Masilamoni; Romel Dator; James Movius; Patrick Aro; Yoland Smith; Jing Zhang
Journal:  Biochim Biophys Acta       Date:  2015-01-22

Review 3.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

4.  Fear potentiated startle increases phospholipase D (PLD) expression/activity and PLD-linked metabotropic glutamate receptor mediated post-tetanic potentiation in rat amygdala.

Authors:  Balaji Krishnan; Michael T Scott; Sebastian Pollandt; Bradley Schroeder; Alexander Kurosky; Patricia Shinnick-Gallagher
Journal:  Neurobiol Learn Mem       Date:  2015-12-31       Impact factor: 2.877

Review 5.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

6.  Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: protein carbonylation is diminished by ascorbic acid.

Authors:  Juan Chavez; Woon-Gye Chung; Cristobal L Miranda; Mudita Singhal; Jan F Stevens; Claudia S Maier
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739

7.  Proteomic analysis of lymphoblastoid cells from Nasu-Hakola patients: a step forward in our understanding of this neurodegenerative disorder.

Authors:  Serena Giuliano; Anna Maria Agresta; Antonella De Palma; Simona Viglio; Pierluigi Mauri; Marco Fumagalli; Paolo Iadarola; Lorenza Montalbetti; Roberta Salvini; Anna Bardoni
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

Review 8.  Mitochondrial dysfunction and oxidative stress in aging and cancer.

Authors:  Anna V Kudryavtseva; George S Krasnov; Alexey A Dmitriev; Boris Y Alekseev; Olga L Kardymon; Asiya F Sadritdinova; Maria S Fedorova; Anatoly V Pokrovsky; Nataliya V Melnikova; Andrey D Kaprin; Alexey A Moskalev; Anastasiya V Snezhkina
Journal:  Oncotarget       Date:  2016-07-19

9.  Oxidative stress impairs energy metabolism in primary cells and synovial tissue of patients with rheumatoid arthritis.

Authors:  Emese Balogh; Douglas J Veale; Trudy McGarry; Carl Orr; Zoltan Szekanecz; Chin-Teck Ng; Ursula Fearon; Monika Biniecka
Journal:  Arthritis Res Ther       Date:  2018-05-29       Impact factor: 5.156

Review 10.  Basic mechanisms of neurodegeneration: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.